Latin America Women’s Health Market Size & Outlook
Latin America women’s health market, 2018-2030 (US$M)
Related Markets
Latin America women’s health market highlights
- The Latin America women’s health market generated a revenue of USD 2,191.2 million in 2023.
- The market is expected to grow at a CAGR of 6.8% from 2024 to 2030.
- In terms of segment, contraceptives was the largest revenue generating application in 2023.
- Endometriosis & Uterine Fibroids is the most lucrative application segment registering the fastest growth during the forecast period.
- Country-wise, Mexico is expected to register the highest CAGR from 2024 to 2030.
Latin America data book summary
| Market revenue in 2023 | USD 2,191.2 million |
| Market revenue in 2030 | USD 3,476.5 million |
| Growth rate | 6.8% (CAGR from 2023 to 2030) |
| Largest segment | Contraceptives |
| Fastest growing segment | Endometriosis & Uterine Fibroids |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Hormonal Infertility, Contraceptives, Postmenopausal Osteoporosis, Endometriosis & Uterine Fibroids, Menopause, Polycystic Ovary Syndrome (PCOS) |
| Key market players worldwide | AbbVie Inc, Bayer AG, Merck & Co Inc, Pfizer Inc, Teva Pharmaceutical Industries Ltd, Agile Therapeutics Inc, Amgen Inc, Apothecus, Blairex Laboratories, Ferring |
Other key industry trends
- In terms of revenue, Latin America region accounted for 4.9% of the global women’s health market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 17,433.6 million by 2030.
Contraceptives was the largest segment with a revenue share of 43.71% in 2023. Horizon Databook has segmented the Latin America women’s health market based on hormonal infertility, contraceptives, postmenopausal osteoporosis, endometriosis & uterine fibroids, menopause, polycystic ovary syndrome (pcos) covering the revenue growth of each sub-segment from 2018 to 2030.
The large population of women aged over 50 years is one of the crucial factors anticipated to boost the demand for women’s health products in the region. A research study published in 2018 stated that Latin America’s proportion of individuals aged 50 & above is anticipated to increase from 14%–20% in 2018 to approximately 29%–40% in 2050.
Moreover, by 2050, Latin America is predicted to account for 12.5% of hip fractures globally, with the majority being in postmenopausal women. Such factors are fueling the demand for postmenopausal and other women’s health products.
Approximately 95% of the abortions in this region are unsafe. Almost 1 million women are admitted every year owing to complications following unsafe abortion. Furthermore, in this region, there is low adoption of LARCs, such as hormonal implants and intrauterine devices.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Women’s Health Market Scope
Women’s Health Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Latin America women’s health market size, by country, 2018-2030 (US$M)
Latin America Women’s Health Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
